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ABSTRACT
The human Telomerase Reverse Transcriptase (hTERT) gene encodes a rate-
limiting catalytic subunit of telomerase that maintains genomic integrity. Suppression 
of hTERT expression could induce cellular senescence and is considered a potent 
approach for gastric cancer therapy. However, control of hTERT expression and 
function remains poorly understood in gastric cancer. In this study, we demonstrated 
that high expression levels of hTERT in malignant tissues are correlated with poor 
survival probability in gastric cancer patients. Knockdown of hTERT expression 
retarded cell proliferation and cellular senescence, which was confirmed by increased 
protein expression levels of p21cip1 and p27kip1, and decreased phosphorylation of 
Rb. In contrast, overexpression of hTERT increased cell proliferation and decreased 
cellular senescence. Remarkably, the down-regulation of hTERT expression was 
detected in lgals3-/- mouse embryo fibroblasts (MEFs). Knockdown of galectin-3 
decreased the expression of hTERT in gastric cancer cells. Galectin-3 ablation-
induced cellular senescence was rescued by concomitant overexpression of hTERT. 
hTERT ablation-induced cellular senescence and p21cip1 and p27kip1 expression was 
rescued by concomitant overexpression of galectin-3. The size of tumor burdens was 
increased in hTERT-overexpressed gastric cancer cells xenografted mice, whereas it 
was repressed by concomitant depletion of galectin-3. Additionally, we determined 
that the N-terminal domain of galectin-3 directly interacted with hTERT. The telomeric 
activity of hTERT was also decreased by galectin-3 ablation. Taken together, ablation 
of hTERT induces cellular senescence and inhibits the growth of gastric cancer cells, 
suggesting that it could be a potent target in gastric cancer therapy. We also propose 
that galectin-3 is an important regulator of hTERT expression and telomeric activity 
in gastric tumorigenesis.
INTRODUCTION
Gastric cancer is one of the most common 
malignancies worldwide. Although there has been 
increased knowledge of the key molecular signaling 
pathways involved in gastric carcinogenesis, the 
molecular composition of gastric cancer has not been fully 
understood [1, 2]. Currently, surgery is the only treatment 
strategy to cure relatively early-staged gastric cancer; 
however, for patients in an advanced stage, the overall 
survival is poor (approximately 10 months for those who 
receive conventional chemotherapy). Chemotherapy is the 
most common therapy for advanced gastric cancer, but its 
efficacy is limited. Targeted therapy is a new therapeutic 
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approach that might improve the survival of advanced 
gastric cancer patients [3]. Therefore, molecular analyses 
have been vigorously performed for the last decades, and 
results suggest that alterations in the structure and function 
of oncogenes and tumor suppressor genes, genetic 
instability, as well as the acquisition of cell immortality, 
could be relevant in the pathogenesis of gastric cancer. 
Telomerase activation is believed to be a crucial event 
in most immortal cells and cancer cells [4]. However, 
its clinicopathologic significance and the mechanisms 
regulating telomerase activity remain to be clarified in 
gastric cancer.
Eukaryotic chromosomes are capped with repetitive 
telomere sequences that protect the chromosome ends 
against exonucleases and ligases, thus preventing 
fusion, recombination, and degradation [5]. Telomere 
maintenance is often accompanied by an activated 
telomerase to protect genetically damaged DNA from 
normal cell senescence; however, telomerase activation 
through the induction of human Telomerase Reverse 
Transcriptase (hTERT) is an essential step in gastric 
cancer [4] and other cancers [6], suggesting studying 
the functional maintenance of telomerase is important in 
tumorigenesis with senescence [5]. Cellular senescence, a 
state of irreversible cell cycle arrest, is a part of the aging 
program and it involves multiple signaling cascades [7]. 
In general, senescence can be divided into replicative 
senescence and premature senescence. Replicative 
senescence has been described for all metabolically 
active cells that undergo a spontaneous decline in growth 
rate. Notably, ectopic expression of hTERT can prevent 
it. In cancer cells, premature senescence induced by 
oncogenes, named oncogene-induced senescence, and 
plays an important role in preventing the development of 
cancer. This suggests that induction of cellular senescence 
by targeting hTERT is a potential approach for cancer 
therapy. Moreover, most gastric cancers show genetic 
instability, either microsatellite instability or chromosomal 
instability, which is considered an early event in gastric 
carcinogenesis [8]. Based on clinical pathology, up-
regulated expression and activity of hTERT is a critical 
factor in gastric carcinogenesis, however, the regulatory 
mechanisms underlying hTERT expression and function in 
cellular senescence remains poorly understood in gastric 
cancer.
Previously, we reported that galectin-3 regulates 
cellular senescence without oncogenic stress in gastric 
cancer [9]. We also determined, using DNA microarray 
analysis, that ablation of galectin-3 decreased the mRNA 
expression of hTERT [10]. We confirmed that the 
expression of senescence inducers such as p21cip1 and 
p27kip1, was down-regulated by telomerase; moreover, 
galectin-3 also down-regulated their expression. The role 
of galectin-3 and human telomerase subunits with hTERT 
in cellular senescence was confirmed by senescence-
associated β-galactosidase (SA-β-gal) activity. Therefore, 
in this study, we determined the interaction between 
hTERT and galectin-3 to regulate cellular senescence 
in gastric cancer. We demonstrate that hTERT regulates 
cellular senescence and that galectin-3 regulates hTERT 
expression and activation in gastric cancer.
RESULTS
Analysis of hTERT expression and its related 
survival probability in malignant tissues of 
gastric cancer patients
We determined the expression levels of hTERT in 
malignant stomach tissues from gastric cancer patients 
available in the NCBI database (Figure 1A) and performed 
a Kaplan–Meier analysis to generate a survival curve using 
the online resource http://kmplot.com/ and analyzed gene 
sets for gastric cancer patients (Figure 1B). We collected 
eight datasets of gastric cancer patients and compared 
the expression levels of hTERT in malignant and normal 
stomach tissues (Figure 1A). Among eight analyses, only 
two sets showed statistically increased expression of 
hTERT in malignant tissues, when compared to normal 
tissues, and six sets showed no statistical differences 
between malignant and normal tissues. However, 
statistical analysis showed that high expression of hTERT 
correlated with significant lower survival probability, 
when compared to low expression of hTERT in malignant 
stomach tissues from gastric cancer patients (Figure 1B).
Knockdown of hTERT induces cellular 
senescence in gastric cancer cells
First, we determined expression levels of hTERT in 
twelve gastric cancer cell lines (Supplementary Figure 1). 
Among of them, YCC-2, SNU-16, SNU-216, and SNU719 
cells expressed high mRNA levels of hTERT. Based on 
these results, we choose YCC-2 and SNU-216 cells for 
loss of function experiments, and MKN-28 and SNU-638 
cells for gain of function experiments.
After knockdown of hTERT by three kinds of 10 
μM hTERT-specific siRNA for 2 days, determined the 
diminishment of hTERT expression in YCC-2 cells 
(Supplementary Figure 2). And then, we analyzed 
cellular senescence using the SA-β-gal assay (Figure 
1A). Cellular senescence significantly increased in both 
cells lines (46.4% in YCC-2 cells and 27.6% in SNU-
216 cells) compared to control cells. Cell proliferation 
was also reduced by knockdown of hTERT in both cell 
lines (Figure 2B). Therefore, we detected both mRNA and 
protein expression levels of senescence-related molecules 
(Figure 2A and 2B). Knockdown of hTERT slightly 
increased mRNA expression levels of p27kip1 (Figure 2C), 
whereas it drastically increased the protein expression 
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levels of p21cip1 and p27kip1, known cell cycle inhibitors, 
but not p53. Phosphorylation of Rb was decreased by 
knockdown of hTERT (Figure 2D). We attempted to 
determine the expression levels of p16INK4a, but they could 
not be detected in these gastric cancer cells (data not 
shown).
Overexpression of hTERT reduces cellular 
senescence in gastric cancer cells
To determine whether hTERT overexpression 
reduced premature senescence, we prepared an hTERT 
overexpression vector (pcDNA3.0-hTERT) and transiently 
Figure 1: Correlation between tumorigenesis and hTERT expression in gastric cancer patients. A. mRNA expression 
levels of hTERT of malignant tissues and normal tissues from gastric cancer patients are presented as a scatter diagram (GSE13861, 
GSE63089, GSE30727, GSE56807, GSE13195-2845830, 2845831, 2845837, 2845839). B. Kaplan–Meier survival plots demonstrating 
the poor prognostic effect due to the hTERT up-regulation, which correlated with a worse Overall Survival in gastric cancer patients 
(probe1:207199_at_n = 876, probe2:1555271_a_at_n = 631) (http://kmplot.com/analysis).
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transfected it into SNU-638 and MKN-28 cells. Cellular 
senescence and cell proliferation were analyzed using 
the WST assay and SA-β-gal assay (Figure 3A and 3B). 
Overexpression of hTERT reduced cellular senescence 
in cells (15.4% to 7.75% in MKN-28 cells, and 16.7% to 
6.9% in SNU-638 cells) (Figure 3A). Cell proliferation 
was increased in hTERT overexpressed SNU-638 cells 
and MKN-28 cells (Figure 3B). Both mRNA and protein 
expression levels of senescence-related molecules were 
also detected in hTERT overexpressed cells (Figure 3C 
and 3D). The mRNA expression levels of p21cip1, p27kip1, 
and p53 were not altered by hTERT overexpression 
(Figure 3C). Protein expression levels of p21cip1 and p27kip1 
were significantly decreased, but not p53 expression 
levels. Phosphorylation of Rb was also increased by 
overexpression of hTERT (Figure 3D).
These results suggest that expression levels of 
hTERT are related with induction of cellular senescence 
in gastric cancer cells.
Expression levels of hTERT are regulated by 
galectin-3 in gastric cancer cells
Previously, we reported DNA microarray analysis 
results using galectin-3 depleted AGS gastric cancer 
cells [10]. We obtained data demonstrating that hTERT 
expression levels were also reduced in galectin-3 
depleted cells (Supplementary Figure 3). Therefore, we 
determined mRNA expression levels and correlation 
between hTERT and galectin-3 in twelve gastric cancer 
cell lines (Supplementary Figure 1). Notably, we found 
that cell lines with high expression levels of hTERT also 
Figure 2: Ablation of hTERT altered the cell proliferation and cellular senescence of gastric cancer cells. Both YCC-2 
and SNU-216 gastric cancer cells were transfected with scrambled siRNA (scRNA) and hTERT specific siRNA for 48 h. A. Cellular 
senescence was detected by SA-β-galactosidase activity in YCC-2 and SNU-216 gastric cancer cells. The graph shows the percentage of 
SA-β-galactosidase-positive cells. (P < 0.0005) B. Cell proliferation was measured by WST assay in YCC-2 and SNU-216 gastric cancer 
cells. (P < 0.0001) C. Detection of mRNA expression levels of hTERT, p21cip1, p27kip1, and p53 were detected by RT-PCR analysis and D. 
protein expression levels of these were detected by western blot analysis in YCC-2 and SNU-216 gastric cancer cells after transfection with 
scrambled siRNA (scRNA) and hTERT specific siRNA. β-actin was used loading control.
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had high expression levels of galectin-3 (YCC-2, SNU-16, 
SNU-216, and SNU-719 cells). To confirm the regulation 
of hTERT expression by galectin-3, we determined 
expression levels of mTERT in galectin-3 knockout (KO) 
mouse embryonic fibroblasts (MEFs), and observed a 
decrease in mRNA expression of hTERT (Figure 4A). 
Remarkably, it was determined that mRNA expression of 
galectin-3 was also reduced in mTERT KO MEFs (Figure 
4B), suggesting that galectin-3 and mTERT regulate each 
other.
Next, we determined the effect of hTERT on the 
function of galectin-3 in cell proliferation (Figure 4C). 
Overexpression of galectin-3 increased the proliferation 
of SNU-638 cells; however, concomitant 3silencing 
hTERT reduced this galectin-3-induced cell proliferation. 
We determined the effect of hTERT on galectin-3-
related cellular senescence (Figure 4D and 4E). After 
overexpression of galectin-3, hTERT expression was 
increased, whereas p21cip1 and p27kip1 was decreased. 
Notably, this decrease in expression induced by galectin-3 
was restored by hTERT knockdown (Figure 4D). However, 
neither galectin-3 nor hTERT affected p53 expression 
levels (Figure 4D). Overexpression of galectin-3 reduced 
the amount of SA-β-gal positive SNU-638 cells, which 
was re-increased by concomitant knockdown of hTERT 
(Figure 4E). Our results suggest that galectin-3 regulates 
cell proliferation and cellular senescence in an hTERT-
dependent manner.
hTERT function is regulated by galectin-3 in 
gastric cancer cells
Next, we determined whether galectin-3 regulates 
the function of hTERT on the proliferation of gastric 
Figure 3: Overexpression of hTERT altered the cell proliferation and cellular senescence of gastric cancer cells. 
Both MKN-28 and SNU-638 cells were transfected with pcDNA3.0 empty vector (pcDNA3.0) and pcDNA3.0_hTERT for 48 h. 
A. Cellular senescence was detected by β-galactosidase activity in MKN-28 and SNU-638 gastric cancer cells after transfection with a 
pcDNA3.0 empty vector (pcDNA3.0) or pcDNA3.0_hTERT. The graph shows the percentage of β-galactosidase-positive cells. B. Cell 
proliferation was examined in MKN-28 and SNU-638 gastric cancer cell lines after transfection with pcDNA3.0 and pcDNA3.0_hTERT 
(P < 0.0001). C. Detection of mRNA expression levels of hTERT, p21cip1, p27kip1, and p53 were detected by RT-PCR analysis and D. protein 
expression levels of these were detected by western blot analysis in MKN-28 and SNU-638 cells after transfection with pcDNA3.0 and 
pcDNA3.0 hTERT. β-actin was used loading control.
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cancer cells (Figure 5A and 5B). Overexpression of 
hTERT in YCC-2 (Figure 5A) and SNU-216 cells (Figure 
5B) increased cell proliferation, whereas this effect was 
reduced by concomitant knockdown of galectin-3 in both 
cells. The mRNA expression of levels of p21cip1, p27kip1, 
and p53 were not altered after overexpression of hTERT 
and/or knockdown of galectin-3 (Figure 5C). However, 
overexpression of hTERT reduced protein expression 
levels of p21cip1 and p27kip1, which were re-increased after 
knockdown of galectin-3 (Figure 5D). Additionally, p53 
expression level was not affected (Figure 5D). SA-β-
gal positive YCC-2 cells were significantly reduced by 
overexpression of hTERT, but concomitant knockdown 
of galectin-3 increased the amount of SA-β-gal positive 
YCC-2 cells (Figure 5E). This phenomenon was detected 
in SNU-216 cells, too (Figure 5F).
Function of hTERT is regulated by galectin-3 in 
human foreskin fibroblast cells
To further investigate hTERT-related cellular 
senescence, we prepared human foreskin fibroblast cells 
to determine cell proliferation and cellular senescence 
(Figure 6). Overexpression of hTERT increased the 
proliferation of fibroblast cells, but concomitant 
knockdown of galectin-3 reduced the proliferation 
(Figure 6A). The expression of p27kip1 was reduced 
by overexpression of hTERT, whereas concomitant 
knockdown of galectin-3 restored the expression levels 
(Figure 6B). The amount of SA-β-gal positive fibroblast 
cells was significantly reduced by overexpression of 
hTERT, whereas concomitant knockdown of galectin-3 re-
increased this population (Figure 6C). These data strongly 
Figure 4: Detection of expression level of mTERT in galectin-3 knockout mouse embryo fibroblasts (lgals3-/- KO 
MEFs) and expression level of galectin-3 in mTERT knockout mouse embryo fibroblasts (TERT KO MEFs). A. mRNA 
expression levels of mTERT and Galectin-3 in lgals3-/- KO MEFs and B. mRNA expression levels of mTERT and galectin-3 in TERT KO 
MEFs were detected by RT-PCR analysis. β-actin was used loading control. C-E. SNU-638 gastric cancer cells were transfected with 
pcDNA3.0 alone, pcDNA3.0-galectin-3 alone, hTERT siRNA alone, and hTERT siRNA and pcDNA3.0-galectin-3 for 48 h. C. Each cell 
plate was stained with Crystal violet solution and showed by photographs (left panel), and cell proliferation in each cell plate was measured 
by WST assay and presented by quantitative graphs (right panel). D. Detection of mRNA expression levels of galectin-3, hTERT, p21cip1, 
p27kip1, and p53 were detected by RT-PCR analysis and protein expression levels of these were detected by western blot analysis in SNU-
638 gastric cancer cells. β-actin was used loading control. E. Cellular senescence was detected by SA-β-galactosidase activity in SNU-638 
cells. The graph shows the percentage of SA-β-galactosidase-positive cells.
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Figure 5: Depletion of galectin-3 after hTERT overexpression on the cell proliferation and cellular senescence of 
human gastric cancer cells. A. YCC-2  gastric cancer cells were transfected with scRNA alone, pcDNA3.0-hTERT alone, pcDNA3.0-
hTERT and galectin-3 siRNA, and galecitn-3 siRNA alone for 48 hr. Each cell plate was stained with Crystal violet solution and showed by 
photographs (left panel), and cell proliferation in each cell plate was measured by WST assay and presented by quantitative graphs (right 
panel). B. SNU-216 gastric cancer cells were transfected with scRNA alone, pcDNA3.0-hTERT alone, pcDNA3.0-hTERT and galectin-3 
siRNA, and galecitn-3 siRNA alone for 48 hr. Each cell plate was stained with Crystal violet solution and showed by photographs (left 
panel), and cell proliferation in each cell plate was measured by WST assay and presented by quantitative graphs (right panel). C. Detection 
of mRNA expression levels of hTERT, galectin-3, p21cip1, p27kip1, and p53 were detected by RT-PCR analysis in both YCC-2 and SNU-216 
gastric cancer cells. β-actin was used loading control. D. Detection of protein expression levels of hTERT, galectin-3, p21cip1, p27kip1, and 
p53 were detected by western blot analysis in both YCC-2 and SNU-216 gastric cancer cells. β-actin was used loading control. Cellular 
senescence was detected by SA-β-galactosidase assay in E. YCC-2 and F. SNU-216 gastric cancer cells. The graph shows the percentage 
of SA-β-galactosidase-positive cells.
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support that galectin-3 regulates both the expression and 
function of hTERT in cellular senescence.
Galectin-3 directly interacts with hTERT to 
regulate its telomeric activity
To determine how galectin-3 regulates the function 
of hTERT, we performed an immunoprecipitation (IP) 
analysis to detect their interaction (Figure 7A). For this 
purpose, we prepared plasmids containing domains of 
galectin-3 (Figure 7B) and performed IP analysis (Figure 
7C). Among several domains of galectin-3, overexpression 
of the domain of 63–250 amino acid or the 111–250 
amino acid domain showed no interaction with hTERT, 
suggesting that the 1–63 amino acid domain could interact 
with hTERT.
Moreover, we also performed a telomere repeat 
amplification protocol (TRAP) assay to detect the 
telomeric activity of hTERT by overexpression of 
galectin-3 (Figure 7D). Overexpression of full-length 
galectin-3 induces telomere amplification, whereas 
overexpression the 111–250 amino acid domains could 
not induce the same effect, suggesting that galectin-3 
enhances the telomeric activity of hTERT.
Function of hTERT is regulated by galectin-3 in 
gastric cancer mouse models in vivo
To analyze the in vivo effect of hTERT 
overexpression and galectin-3-depletion in gastric cancer 
tumorigenesis, we prepared stable cell lines (Figure 
8A) and xenografted them into nude mice (Figure 
8B–8D). YCC-2 cells were prepared as follows: pLKO-
vector only expressed, pBABE_hTERT - hTERT over-
expressed, pBABE_TERT/shRNA_galectin-3 - hTERT 
overexpressed and galectin-3 depleted, and shRNA_
galectin-3 - galectin-3 depleted. The largest tumor burden 
was detected in hTERT overexpressed YCC-2 cells 
xenografted mice (Figure 8B and 8C). However, the 
tumors that were xenografted by overexpressed hTERT 
Figure 6: Depletion effect of galectin-3 on the overexpression of hTERT in both the cell proliferation and cellular 
senescence of human foreskin fibroblasts. A. Human Foreskin fibroblasts were transfected with scRNA alone, pcDNA3.0-hTERT 
alone, pcDNA3.0-hTERT and galectin-3 siRNA, and galecitn-3 siRNA alone for 48 hr. Each cell plate was stained with Crystal violet 
solution and showed by photographs (left panel), and cell proliferation in each cell plate was measured by WST assay and presented by 
quantitative graphs (right panel). B. Detection of mRNA expression levels of hTERT, galectin-3, and p27kip1 were detected by RT-PCR 
analysis and protein expression levels of these were detected by western blot analysis in human Foreskin fibroblasts. β-actin was used 
loading control. C. Cellular senescence was detected by SA-β-galactosidase activity in human Foreskin fibroblasts. The graph shows the 
percentage of SA-β-galactosidase-positive cells.
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and depleted galectin-3 cells were significantly smaller 
than those prepared by overexpressed hTERT cells, 
suggesting that the hTERT-promoted gastric tumor growth 
was regulated by galectin-3. Furthermore, galectin-3 
depleted stable cells did not form tumors as well as in 
pLKO stable cells.
We also examined expression levels of galectin-3 
and TERT in tumor tissues from xenografted mice. 
Overexpression of hTERT in tumors from YCC-2 
cells had unchanged the expression level of galectin-3, 
whereas hTERT expression was significantly decreased 
in tumors from galectin-3 depleted YCC-2 cells (Figure 
8D). Therefore, we confirmed that TERT expression was 
also significantly regulated by galectin-3 in in vivo gastric 
tumors.
DISCUSSION
Telomerase is a reverse transcriptase that adds 
telomeric repeats to the ends of eukaryotic chromosomes. 
Human telomerase reverse transcriptase (hTERT) is 
observed in 80–90% of human tumors including gastric 
cancer, and plays a critical role in the regulation of 
telomerase activity, which is responsible for endless 
cell growth [11, 12]. In this study, we confirmed mRNA 
expression levels of hTERT in both normal and malignant 
stomach tissues from gastric cancer patients (data analyzed 
from the GEO dataset in NCBI). There were no differences 
in mRNA expression levels of hTERT between normal and 
malignant stomach tissues in six of eight sets of clinical 
data from gastric cancer patients. However, the survival 
Figure 7: Detection of interaction between hTERT and galectin-3 through the N-terminal domain of galectin-3 and 
increased telomeric activity after galectin-3 overexpression. A. Interaction between galectin-3 and hTERT was performed by 
Immunoprecipitation (IP) assay in HEK293 cells. IP assay was described in “Materials and Methods”. B. Schematic model of galectin-3 
delayed mutants; Flag-galectin-3 domains (1–250 aa as the full length; 13-250, 33–250, 63–250, and 111–250 aa. C. Each deleted mutants 
of galectin-3 and HA-hTERT were co-transfected in HEK293 cells. IP assay with Flag and HA antibodies to detect the interaction of hTERT 
with galectin-3 domains were performed D. Telomere Repeat Amplification Protocol (TRAP) Assay with galectin-3 binding domain (Full 
length of galectin-3), galectin-3 wild type, galectin-3 non-binding domain (galectin-3 111–250 AA), and HA-hTERT. TRAP assay was 
described in “Material and Methods”.
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probability is significantly different between high and low 
hTERT expression in malignant tissues from gastric cancer 
patients. The gastric cancer patients with high expression 
of hTERT had a statistically poorer survival probability 
than those with low expression of hTERT. It should be 
noted that high expression of hTERT mRNA in malignant 
tissues, but not normal tissues, suggesting the regulation of 
hTERT function has an effect on tumor malignancy.
First, we determined whether expression of hTERT 
is important in tumor growth, we investigated the effect 
of hTERT by loss-of function and gain-of function 
analysis on gastric cancer cell proliferation. Knockdown 
of hTERT significantly delayed the growth of gastric 
cancer cells; conversely, overexpression of hTERT 
increased their growth. Moreover, we determined the 
effect of hTERT on cellular senescence in gastric cancer 
cells. Cellular senescence is defined as a quiescent state 
of proliferative arrest despite preservation of cell viability 
and maintained metabolic activity [13]. The permanence 
of senescence growth arrest enforces the senescence 
response and suppresses the development of cancer [14]. 
Telomere shortening is a mark of cellular senescence, a 
type of aging. Functional telomeres prevent DNA repair 
machineries, cells that rapidly respond and attempt repair, 
but shortened telomeres lose their function, and cells are 
forced to cell cycle arrest and cellular senescence. In 
human cancers, hTERT blocks the shortening of telomeres, 
thereby preventing genomic instability and enhancing 
cell cycle progression. In this study, we confirmed 
that ablation of hTERT significantly enhanced cellular 
Figure 8: Knockdown of galectin-3 reduces tumor burden in gastric cancer cell xenografted mice, effect that is reversed 
by overexpression of hTERT. A-D. Lentivirus expressing galectin-3 specific shRNA or retrovirus overexpressing hTERT was prepared 
and their employed stable YCC-2 gastric cancer cells were established for in vivo study. Lentivirus expressing LacZ shRNA was used as 
a control and retrovirus overexpressing a vector targeting pBABE-control was used as a control. Mice (n = 5 per group) were inoculated 
subcutaneously into both flanks with 1 × 106 cells of each YCC-2 cells. A. hTERT overexpression and galectin-3 depletion were confirmed 
by RT-PCR analysis. β-actin was used loading control. B-C. Photographs B. and quantification of tumor formation C. was performed by 
measuring tumor size and weight 30 days after inoculation. The error bars indicate 95% confidence intervals: *, P = 0.001; **, P = 0.0015, 
two-sided t-test. All statistical tests were two-sided. D. Immunohistochemistry (IHC) analysis was performed to detect the expression level 
of galectin-3 and hTERT in tumors in in vivo mouse models. Method of IHC analysis was described in “Materials and Methods”. Scale bar 
presents 100 μM.
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senescence in gastric cancer cells. Notably, ablation of 
hTERT increased the protein expression of cell cycle 
inhibitors such as p21cip1 and p27kip1. However, ablation of 
hTERT did not effect on the expression of p53. Usually, 
shortened telomeres elicit a DNA damage response, but 
do not attempt DNA repair, which in turns activates p53 
[15]. In this study, we used both cells; YCC-2 cells are p53 
wild-type and SNU-216 cells are p53 hot-spot mutated. 
However, knockdown or overexpression of hTERT could 
not change p53 expression, strongly suggested that hTERT 
regulates cellular senescence in a p53-independent manner 
in gastric cancer cells. We are able to suggest the non-
telomeric activity of hTERT is also important in cellular 
senescence and gastric tumorigenesis [16]. Previously, 
we determined the telomerase activity-independent TERT 
function may contribute to cancer development and aging 
independently of telomere lengthening [17]. It is also 
published the non-telomeric activity of TERT [18, 19]. 
They determined that TERT directly regulates expression 
of Wnt/β-catenin target genes, including Myc, through 
physical association. Wnt/β-catenin signaling could 
regulate the expression level of p21cip1 and p27kip1 [20]. It 
is interesting how hTERT regulates the expression level of 
p21cip1 and p27kip1, but it is needed to further study.
We explored another pathway which induces cellular 
senescence, the p16INK4a/pRB pathway. We detected a 
decrease in Rb phosphorylation. However, we could not 
detect the expression of p16INK4a in gastric cancer cells used 
in this study. Previously, we demonstrated that galectin-3 
interacts with Rb and regulates its phosphorylation 
[9], and knockdown of galectin-3 decreased the mRNA 
expression of hTERT [10]. Therefore, we examined 
whether galectin-3 regulates the expression of hTERT 
and its function on the regulation of cellular senescence. 
Knockdown of galectin-3 significantly decreased hTERT 
expression levels in gastric cancer cells. The expression 
of mTERT was diminished in galectin-3 KO MEFs. 
Knockdown of galectin-3 induced-cellular senescence was 
decreased by overexpression of hTERT in gastric cancer 
cells. It was determined that the telomeric activity of 
hTERT was regulated by galectin-3. These results strongly 
suggested that galectin-3 regulates hTERT expression and 
telomeric activation.
Interestingly, we detected that the expression 
of galectin-3 was reduced in mTERT KO MEFs. It 
suggested that galectin-3 and hTERT modulate each 
other. As evidence, we determined the direct interaction 
between hTERT and galectin-3. This direct interaction 
could regulate the functions of each other, at least on 
the induction of cellular senescence. It is still unknown 
how TERT regulates the expression level of galectin-3. 
However, the expression level of p21cip1 and p27kip1 and the 
induction of cellular senescence could be occurred through 
TERT regulated-galectin-3.
Taken together, we considered that high expression 
of hTERT leads to poor survival probability in gastric 
cancer patients and the up-regulated activity of hTERT 
could be a cause in the development of gastric cancer. 
Ablation of hTERT significantly induced cellular 
senescence and inhibited the proliferation of gastric cancer 
cells. Furthermore, the expression and activity of hTERT 
on cellular senescence was regulated by galectin-3. 
Therefore, this study suggests that hTERT could be 
potent prognostic and therapeutic targets in gastric cancer 
therapy; further galectin-3 is an important regulator 
of hTERT expression and telomeric activity in gastric 
tumorigenesis.
MATERIALS AND METHODS
Cell culture and siRNA transfection
The 12 human gastric cancer cell lines (AGS, 
MKN28, YCC-2, KATOIII, SNU-1, SNU-5, SNU-16, 
SNU-216, SNU-601, SNU-638, SNU-668, and SNU-719) 
obtained from the Korea Cell Line Bank were cultured 
in RPMI 1640 medium supplemented with 5% fetal 
bovine serum (FBS) and 1% Antibiotics (Invitrogen) and 
maintained at 37°C in a humidified incubator with a 5% 
CO2 atmosphere as previously described [21–24]. Human 
galectin-3 and human TERT (hTERT) siRNA transfection 
was performed with Lipofectamine RNAiMAX reagent 
(Invitrogen) following manufacturer’s instructions 
[25]. The coding strand of galectin-3 siRNA was 
5′-AUAUGAAGCACUGGUGAGGUCUAUG-3′ and was 
purchased from Invitrogen; the coding strand of hTERT 
siRNA was 5′-UGAUUUCUUGUUGGUGACAUU-3′ 
and was purchased from Genolution (Seoul, Korea) [26].
RNA isolation and reverse transcription-
polymerase chain reaction (RT-PCR)
Total RNA was extracted from human gastric cancer 
cells and gastric cancer patient tissues using the TRIzol 
reagent (Invitrogen) according to the manufacturer’s 
protocol [27]. The RT reaction was carried out using 
a Reverse Transcription system (Promega), and the 
PCR was performed using the Ex-taq DNA polymerase 
(TaKaRa). The primer sequences were as follows: 
galectin-3: 5′-CAGTGCTCCTGGAGGCTATC-3′ (sense) 
and 5′-AAGGGGAAGGCTGACTGTCT-3′ (anti-sense); 
hTERT: 5′-GAACTTGCGGAAGACAGTGG-3′ (sense) 
and 5′-ATGCGTGAAACCTGTACGCCT-3′ (anti-sense); 
mTERT; 5′-ATGACCCGCGCTCCTCGTTGC-3′ (sense) 
and 5′-GACAGCAGAGATGTGGAGCTG-3′ (anti-sense); 
p21cip1: 5′-ATGAAATTCACCCCCTTTCC-3′ (sense) 
and 5′-CCCTAGGCTGTGCTCACTTC-3′ (anti-sense); 
p27kip1: 5′-AGATGTCAAACGTGCGAGTG-3′ (sense) 
and 5′-TCTCTGCAGTGCTTCTCCAA-3′ (anti-sense); 
p53: 5′-GGCCCACTTCACCGTACTAA-3′ (sense) and 
5′-GTGGTTTCAAGGCCAGATGT-3′ (anti-sense); β- 
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actin: 5′-AGCCTCGCCTTTGCCGA-3′ (sense) and 5′-CT 
GGTGCCTGGGGCG-3′ (anti-sense).
Cell proliferation detection assay
YCC-2, SNU-216, MKN-28, SNU-638, and human 
fibroblast cells were plated in 96-well culture plates (3 
× 103 cells/well). After incubation for 24 h, YCC-2 and 
SNU-216 cells were transfected with scRNA and hTERT 
siRNA. MKN-28 and SNU-638 cells were transfected 
with an empty vector and an hTERT overexpression 
vector. After transfection for 48 h, the WST-1 solution 
(Daeil, Korea) was subsequently added to each well. After 
1 h of additional incubation, the plate was shaken gently. 
The absorbance was measured on an ELISA reader at a 
test wavelength of 450 nm [28, 29].
Western blot analysis
Western blot analysis was carried out as described 
previously [30, 31]. Briefly, cells were lysed in RIPA 
buffer (Biosesang, Seoul, Korea) containing a protease 
inhibitor cocktail (Sigma), followed by sonication on ice. 
The cell lysate was centrifuged and the supernatant was 
collected. Then, 20 μg of protein was subjected to SDS-
PAGE and transferred to PVDF transfer membranes (GE 
healthcare). After being blocked with 5% skim milk for 1 
h, the membrane was incubated with a primary antibody 
dissolved in 5% BSA overnight at 4°C. After that, the 
membrane was incubated with a secondary antibody for 1 
h, followed by detection with an ECL kit (GE healthcare) 
using LAS 3000. The following antibodies were used: 
anti-β-actin, anti-Rb, anti-pRb, anti-galectin-3, anti-p21, 
anti-p27, anti-p53, and anti-TERT (Santa Cruz).
Immunoprecipitation assays
Cell lysate containing 750 μg of protein was pre-
cleared by incubation with 40 μL of protein-A/G linked 
agarose beads (Santa Cruz) for 1 h at 4°C. After the 
beads were spun down, the supernatant was incubated 
with 1 μg of a specific antibody (anti-HA or anti-FLAG, 
respectively) overnight at 4°C, followed by incubation 
with 40 μL of protein-A/G agarose beads for 1 h. Mouse 
IgG (Santa Cruz) was used as the negative control. After 
the incubation, beads were washed 3 times in RIPA 
buffer before being dissolved in SDS-PAGE loading 
buffer. Western blot analysis was performed as described 
above.
Infection of galectin-3 shRNA expressing lenti-
viral vectors
Galectin-3 shRNA was purchased from Sigma 
shRNA Bacterial Glycerol Stock. Lentivirus particles were 
generated using three plasmids: VSVG, RSV-REV, and 
PMDLg/pPRE, and were co-transfected with galectin-3 
shRNA in HEK293FT cells that were transfected as 
described previously [32].
Infection of hTERT pBABE expressing retro-
viral vectors
pBABE-neo-hTERT was obtained from Addgene 
[33]. Retrovirus particles were generated using two 
plasmids, VSVG and GAG/POL, and were co-transfected 
with pBABE-neo-hTERT in HEK293FT cells that were 
transfected as described previously.
TRAP assay
TRAP was performed as previously described 
[34]. Briefly, cells were lysed with 1 X CHAPS powder 
(GE Healthcare, MO, USA) containing RNase inhibitor 
on ice for 30 min. After centrifugation at 13,000 rpm 
for 10 min, the protein concentration in the supernatant 
was determined to then incubate at 30°C for 20 min for 
telomere extension. The extended products were PCR 
amplified using TS and ACX primers for 33 cycles 
(denaturation at 94°C for 30 s, annealed at 59°C for 30 
s and extended at 72°C for 60 s). NT and TSNT primers 
were added as an internal control. The PCR products were 
separated by 12.5% non-denaturing PAGE in 0.5 TBE. 
Silver staining was carried out as previously described 
[35]. After electrophoresis, the gels were fixed with a 
solution containing 0.5% acetic acid and 10% ethanol for 
15 min and stained with 0.2% AgNO2 for 10 min. The 
stained gel was quickly washed and developed with 0.1% 
formaldehyde and 3% NaOH for 20 min.
Preparation of human gastric cancer 
xenografted mice
All animal experiments were approved by the 
Institutional Review Board of Yonsei University College 
of Medicine and performed at specific pathogen-free 
facilities under conditions in accordance with the 
Guidelines for the Care and Use of Laboratory Animals 
Resources of Yonsei University College of Medicine. 
The preparation of xenografted mice was performed as 
described previously [36, 37].
Statistical analysis
Significant differences between treatment and 
control groups were determined using the Student’s paired 
t-test and ANOVA for multiple samples, if indicated. 
Differences were considered significant if the P value was 
less than 0.05. Analysis of data was performed using the 
Prism 5 software.
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Kaplan-meier analysis of relapse-free survival
Kaplan-Meier analysis of survival curve was 
generated using the online resource http://kmplot.com/
analysis and gene set for gastric cancer patients.
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